Breast self-reconstruction: The Promise of Breast Reconstruction with patients’...
Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue
LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery. MATTISSE technology uses a Tissue Engineering Chamber implanted in...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
regenera
A natural breast for cancer survivors: resorbable implant su...
4M€
Cerrado
FJC2019-039925-I
Development of 3D printed biodegradable scaffolds for tissue...
50K€
Cerrado
RTC-2016-5386-1
BIOMATERIALES PARA REGENERACIÓN OSEA CON PROPIEDADES TERMO...
184K€
Cerrado
SAF2017-83118-R
ARQUITECTURAS POLIMERICAS 3D ACTIVAS PARA MEDICINA REGENERAT...
127K€
Cerrado
SAF2016-76150-R
DESARROLLO DE BIOSCAFFOLDS PERSONALIZADOS 3D DUALES, BIOMIME...
90K€
Cerrado
REBORN
Full human based multi scale constructs with jammed regenera...
2M€
Cerrado
Información proyecto MATTISSE
Duración del proyecto: 24 meses
Fecha Inicio: 2022-09-14
Fecha Fin: 2024-09-30
Líder del proyecto
LATTICE MEDICAL
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
3M€
Descripción del proyecto
LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery. MATTISSE technology uses a Tissue Engineering Chamber implanted in the former breast and made of 3D printed biocompatible and bioabsorbable polymer. MATTISSE regenerates autologous adipose tissue within 3-6 months, women recover a full breast in 18 months with a fully degraded implant at an affordable price and free from numerous surgical procedures. There is no longer any risk related to silicone implants thanks to the complete recovery with natural tissue.
After validating the effectiveness of the MATTISSE medical device on animal models, this project aims at performing the mandatory clinical studies to launch the product on the EU market with the CE mark. A commercial team will be recruited to define and implement a marketing plan to ensure the success of MATTISSE. Lattice Medical plans to support 40000 women by 2030.